Literature DB >> 5968918

Peptide analysis of the inclusions of erythroid cells in beta-thalassemia.

P Fessas, D Loukopoulos, A Kaltsoya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5968918     DOI： 10.1016/0304-4165(66)90216-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  10 in total

Review 1.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  Balanced globin chain synthesis in hereditary persistence of fetal hemoglobin.

Authors:  C L Natta; G A Niazi; S Ford; A Bank
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

3.  Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia.

Authors:  Y W Kan; D G Nathan; H F Lodish
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

4.  Hemoglobin synthesis in beta-thalassemia: the properties of the free alpha-chains.

Authors:  A Bank
Journal:  J Clin Invest       Date:  1968-04       Impact factor: 14.808

5.  Mild thalassemia: the result of interactions of alpha and beta thalassemia genes.

Authors:  Y W Kan; D G Nathan
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

6.  Inhibition of synthesis of fetal hemoglobin by an isoleucine analogue.

Authors:  G R Honig
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

7.  Influence of hemoglobin precipitation on erythrocyte metabolism in alpha and beta thalassemia.

Authors:  D G Nathan; T B Stossel; R B Gunn; H S Zarkowsky; M T Laforet
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

8.  Hemoglobin Philly (beta 35 tyrosine phenylalanine): studies in the molecular pathology of hemoglobin.

Authors:  R F Rieder; F A Oski; J B Clegg
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

9.  Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia.

Authors:  Yi Kong; Suiping Zhou; Anthony J Kihm; Anne M Katein; Xiang Yu; David A Gell; Joel P Mackay; Kazuhiko Adachi; Linda Foster-Brown; Calvert S Louden; Andrew J Gow; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 10.  α-Globin as a molecular target in the treatment of β-thalassemia.

Authors:  Sachith Mettananda; Richard J Gibbons; Douglas R Higgs
Journal:  Blood       Date:  2015-04-13       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.